That the Parliament welcomes the trial of a new drug for the treatment of ectopic pregnancy by a team led by the University of Aberdeen; notes that the trial, which, it understands, is backed by £1.6 million from the Medical Research Council and National Institute for Health and Care Research, will investigate whether a drug called mifepristone is more effective at treating ectopic pregnancy than the current medical treatment; understands that around 1 in 80 pregnancies are ectopic, where the embryo starts to grow in the wrong place, which can have life-threatening complications requiring emergency surgery; believes that, if successful, this trial could lead to the first major advance in the medical management of ectopic pregnancy in over 20 years; wishes Dr Andrea Woolner, Senior Clinical Lecturer at the University of Aberdeen, and the team of experts from the Universities of Edinburgh, Nottingham and Birmingham, University College London, Imperial College London, Monash University in Australia and The Ectopic Pregnancy Trust well as they proceed with the trial, and hopes that what it sees as this crucial work can lead to a new way of treating ectopic pregnancy that reduces the need for surgery.